Welcome: Guest | Site Use Options | Register | Login |

Valentis Inc

Valentis Inc

Profile last edited on: 2/27/2019
863-A Mitten Road
Burlingame, CA 94010
  (650) 697-1900
Business Identifier: Non-viral gene-based therapies
Public Profile:
A complex story to some extent indicative of the early years of Biotech. The merger of Megabios Corporation and GeneMedicine, Inc. in March 1999 originally formed Valentis Inc. (NASDAQ:VLTS), based in Burlingame, CA and addressing development of procducts for peripeheral arterial disease. Organized around development of gene medicine biopharmaceuticals, at the time Vanetis had three product platforms for the development of novel therapeutics: the gene medicine, GeneSwitch and DNA vaccine platforms, Valentis had developed synthetic vaccine delivery systems based on several classes of polymers and had proprietary PINC (polymeric, non-condensing) polymer-based delivery technologies for intramuscular administration providing for higher and more consistent levels of antigen production. In 2006 San Diego based Inivio Biomedical (developing late-stage cancer therapies) acquired from Valentis its gene regulation, a synthetic gene delivery system, some catioic lipids and some expression technologies. In October of the same year, Valentis signed a merger agreement with Urigen Inc - also based in Burlingame. The latter firm took over the VLTS, shifted trading to OTC and ceasd trading in June 2007.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920